DRKS00022836尚未招募不适用
Treatment of Major Depressive Disorder with Ketamine - retrospective data analysis
Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Freiburg0 个研究点目标入组 50 人开始时间: 2020年8月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •All Patients with Major Depressive Disorder who were treated between 2014 and July 2020 in the Dept. of Psychiatry Freiburg (ward 5) at minimum once with ketamine or esketamine for an individual treatment trial.
- •The study population comprises about 50 subjects with about 600 single treatments.
排除标准
- •All patients who do not fulfill the inclusion criteria.
研究者
相似试验
进行中（未招募）
1 期
A study to look at Ketamine as an additional treatment for people with depressioMajor DepressionEUCTR2019-003109-92-IETrinity College Dublin104
进行中（未招募）
1 期
Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep TrialDepressionEUCTR2016-004764-18-IESt Patrick’s Mental Health Services25
进行中（未招募）
1 期
Ketamine in treatment resistant major depression (TRD)Therapy resistant depressionEUCTR2010-023414-31-DEMedizinische Fakultät. Otto von Guericke Universität
已完成
2 期
Ketamine in treatment resistant major depression (TRD) -A placebo controlled, double blind, randomized trial of efficacy, safety and response prediction by resting state fMRIwith healthy volunteersF33Recurrent depressive disorderDRKS00003527Otto-von-Guericke University MagdeburgMedical Faculty91
已完成
不适用
Ketamine in treatment-resistant major depressioTreatment-resistant major depressionMental and Behavioural DisordersDepressionISRCTN28417759niversity of Kuopio (Finland)100